Precision Medicine Adaptive Network Platform Trial in Hypoxemic Acute Respiratory Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Baricitinib
Related studies linked through entity extraction aliases.
TPO-RA Plus Baricitinib vs. TPO-RA for ITP
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
JAK Signaling in Depression and Cognition in Male Football Players
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Therapeutics for Moderate and Severe Dengue
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Baricitinib for Post-HSCT Persistent Thrombocytopenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Biologics in Folliculitis Decalvans : an Adaptative Trial Research
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Status
- RECRUITING
- Phase
- PHASE3
JAK Signaling in Depression
- Status
- RECRUITING
- Phase
- PHASE2
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
- Status
- RECRUITING
- Phase
- PHASE2
Baricitinib in the Treatment of Intestinal Behçet's Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Vitiligo, New Treatment and Serum s100B
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
- Status
- RECRUITING
- Phase
- PHASE2